Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
View Older Stories View More Recent Stories
-
Piper Jaffray Initiates Coverage on Level 3 (LVLT) with a Neutral
-
Piper Jaffray Initiates Coverage on Sprint Nextel (S) with a Neutral; Still a Turnaround Story
-
Piper Jaffray Initiates Coverage on Equinix (EQIX) with a Buy; Peer Group Leader
-
Piper Jaffray Initiates Coverage on Windstream (WIN) with a Neutral; Potentially Open To M&A
-
Piper Jaffray Initiates Coverage on Frontier Communications (FTR) with a Neutral; Premium Valuation, But Strong Mgmt and M&A Potential
-
Piper Jaffray Initiates Coverage on Crown Castle (CCI) with a Neutral; Valuation Less Attractive
-
Piper Jaffray Initiates Coverage on Qwest Communications (Q) with a Neutral
-
Notable Analyst Rating Changes 4/23: MS, EBAY, TIN, BRCD Upgraded; VMW, FFIV, PKG, CTXS Downgraded
-
Piper Jaffray Initiates Coverage on Suntech Power (STP) with a Neutral; Wait For Pullback
-
Piper Jaffray Initiates Coverage on American Superconductor (AMSC) with a Neutral
-
Apple (AAPL) Kills iPhone Sales Estimates, Selling 3.8M For the Quarter
-
Apple (AAPL) Earnings Q2 Preview; Beat Expected, But By How Much?
-
Piper Jaffray Upgrades Astec Industries (ASTE) to Neutral
-
Piper Jaffray Upgrades The Andersons (ANDE) to Buy
-
Morning Movers 4/17: DRYS, TEL, ICUI, MHP, TPX Higher; CYT, MGM, HNSN, MEG, AOS Lower
-
Hansen Medical (HNSN) Price 11.7M Shares at $3.25
-
Hansen Medical (HNSN) Announces Common Stock Offering
-
Rosetta Stone (RST) IPO Surges Higher
-
Rosetta Stone (RST) IPO Prices At $18, Above Expected Range
-
Bridgepoint Education (BPI) IPO Trades Higher
-
Morning Movers 4/15: PJC, SYT, GM, IP, CSX Higher; GRRF, CYNO, RJF, BKC, FSC, BTU, SKYW Lower
-
Piper Jaffray (PJC) Tops Q1 View By 6c
-
Fidelity National Financial (FNF) Prices 15.8M Shares at $19
-
Trading Radar for 4/15: Abbott (ABT), Peabody (BTU), AMR Corp. (AMR), Polycom (PLCM), Landstar (LSTR) Report; CPI, Industrial Production, Crude Inventories, Fed's Beige Book Due
-
Goldman Sachs Starts Piper Jaffray (PJC) at Neutral
-
Notable Analyst Rating Changes 4/14: BRCD, ALB, DPS, OMI, PL Upgraded; SNDA, BYD, STX, ESI Downgraded
-
Piper Jaffray Initiates Coverage on Luminex (LMNX) with a Neutral
-
Piper Jaffray Initiates Coverage on Hologic (HOLX) with a Buy
-
Notable Analyst Rating Changes 4/13: AKS, OMX, CRM, LULU Upgraded; WFC, EBAY, PH, WYNN, COF, ALV Downgraded
-
David Moenning's Daily State of the Markets: 4/13
-
Piper Jaffray Assumes Coverage on Applied Materials (AMAT) and Raises Rating from Neutral to Buy
-
Piper Jaffray Upgrades Brocade (BRCD) to Buy; Most Attractive Valuation in Peer Group
-
Piper Jaffray Downgrades Comverge (COMV) to Neutral After Meeting With Management
-
Piper Jaffray Downgrades MEMC Electronic (WFR) to Neutral; Valuatiion Call
-
Piper Jaffray Maintains a 'Buy' on Anadys Pharmaceuticals (ANDS), Adds To The Alpha List
-
Piper Jaffray Initiates Coverage on ABIOMED (ABMD) with a Buy; Stock Appears Oversold
-
Unusual 11 Mid-Day Movers 4/8: RT, LNC, GKK, BBBY Higher; ITG, SIVB, SIMO, R Lower
-
Piper Jaffray Downgrades Investment Tech Group (ITG) to Neutral
-
Amylin (AMLN) Tumbles as Competitor to Byetta, Novo Nordisk's liraglutide, Does Not Receive FDA Recommendation
-
Notable Analyst Rating Changes 4/3: RIMM, DVN, ICE, ELN Upgraded; DIS, BMY, MON, AKAM Downgraded
-
Piper Jaffray Upgrades Elan Corporation (ELN) to Neutral; Valuation Call
-
Bridgepoint Education (BPI) Sees IPO Price of $14-$16
-
Two Analysts Defend Auxilium (AUXL) After Sell-Off On Xiaflex Hypersensitivity Concerns
-
Solar Stocks Up Again On More Details Of China's 'Green' Stimulus
-
Solar Stocks Rip Higher On Speculation of $30B China Green Stimulus
-
Piper Jaffray Upgrades Regeneron Pharmaceuticals (REGN) to Buy
-
Solar Stocks Retreat After Yesterday's China Windfall, Analysts Chime In
-
Piper Jaffray Maintains a 'Buy' on Osiris Therapeutics (OSIR); Removes From PJC Alpha List
-
Notable Analyst Rating Changes 3/27: AMGN, COP, JCP, UPS, CAG, CPWR Upgraded; FSLR, PBR, UTIW, STP, BHP Downgraded
-
Piper Jaffray Initiates Coverage on BioMarin Pharmaceutical (BMRN) with a Neutral; Several Barriers to Growth in '09
